Richard E. Nelson

6.4k citations

223 papers · 4.5k indexed · 2 hit papers · h-index 32

Impact in

Applied Microbiology and Biotechnology top 0.2%
- Antibiotic Use and Resistance
Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria

Papers in ⓘ

Applied Microbiology and Biotechnology 16
- Antibiotic Use and Resistance 16
Infectious Diseases 38
- Clostridium difficile and Clostridium perfringens research 23
- Antimicrobial Resistance in Staphylococcus 18

Co-authors: Matthew H. Samore (37 shared papers)Scott D. Grosse (2 shared papers)Karim Khader (26 shared papers)Vanessa Stevens (25 shared papers)Lisa C. Richardson (1 shared paper)Kwame A. Nyarko (1 shared paper)Gary E. Raskob (1 shared paper)Joanne LaFleur (20 shared papers)
Journals: Infection Control and Hospital Epidemiology (13 papers)Clinical Infectious Diseases (11 papers)Open Forum Infectious Diseases (7 papers)JAMA Network Open (6 papers)Medical Care (6 papers)
Partner nations: United States Australia Switzerland

In The Last Decade

Richard E. Nelson

202 papers receiving 4.4k citations

Hit Papers

align trajectories log scale

Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017 2020 · 384 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 New England Journal of Medicine
2015 Thrombosis Research

Peers

Countries citing papers authored by Richard E. Nelson

Since Specialization

Citations

This map shows the geographic impact of Richard E. Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Nelson more than expected).

Fields of papers citing papers by Richard E. Nelson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard E. Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Nelson. The network helps show where Richard E. Nelson may publish in the future.

Co-authors

The 25 scholars most cited alongside Richard E. Nelson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Richard E. Nelson Line = papers co-authored together Richard E. Nelson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 223 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017 New England Journal of Medicine ·John A. Jernigan, Kelly M Hatfield, Hannah Wolford, Richard E. Nelson, Babatunde Olubajo, Sujan Reddy, Natalie McCarthy, Prabasaj Paul, L. Clifford McDonald, Alex Kallen, Anthony E. Fiore, Michael Craig, James Baggs Hit paper breakdown →	2020	384
2	The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs Thrombosis Research ·Scott D. Grosse, Richard E. Nelson, Kwame A. Nyarko, Lisa C. Richardson, Gary E. Raskob Hit paper breakdown →	2015	343
3	National Estimates of Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Hospitalized Patients in the United States Clinical Infectious Diseases ·Richard E. Nelson, Kelly M Hatfield, Hannah Wolford, Matthew H. Samore, R. Douglas Scott, Sujan Reddy, Babatunde Olubajo, Prabasaj Paul, John A. Jernigan, James Baggs	2020	162
4	The clinical epidemiology of male osteoporosis: a review of the recent literature Clinical Epidemiology ·Richard E. Nelson, Tina M. Willson, Scott D. Nelson, Jonathan Newbold, Joanne LaFleur	2015	150
5	The cost-effectiveness of telestroke in the treatment of acute ischemic stroke Neurology ·Richard E. Nelson, Gregory M. Saltzman, Elaine Skalabrin, Bart M. Demaerschalk, Jennifer J. Majersik	2011	139
6	Inpatient costs, mortality and 30-day re-admission in patients with central-line-associated bloodstream infections Clinical Microbiology and Infection ·Vanessa Stevens, K. Geiger, Cathleen Concannon, Richard E. Nelson, J. Brown, Ghinwa Dumyati	2013	134
7	Costs and Infant Outcomes After Implementation of a Care Process Model for Febrile Infants PEDIATRICS ·Carrie L. Byington, Carolyn Reynolds, Kent Korgenski, Xiaoming Sheng, Karen Valentine, Richard E. Nelson, Judy A. Daly, Russell J. Osguthorpe, Brent C. James, Lucy A. Savitz, Andrew T. Pavia, Edward B. Clark	2012	131
8	Incidence of Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella Infections in the United States: A Systematic Literature Review Infection Control and Hospital Epidemiology ·Jennifer S. McDanel, Marin L. Schweizer, Victoria Crabb, Richard E. Nelson, Matthew H. Samore, Karim Khader, Amy Blevins, Daniel J. Diekema, Hsiu‐Yin Chiang, Rajeshwari Nair, Eli N. Perencevich	2017	124
9	Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection JAMA Internal Medicine ·Vanessa Stevens, Richard E. Nelson, Elyse M. Schwab-Daugherty, Karim Khader, Makoto Jones, Kevin A. Brown, Tom Greene, Lindsay Croft, Melinda M. Neuhauser, Peter Glassman, Matthew Bidwell Goetz, Matthew H. Samore, Michael Rubin	2017	120
10	Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction JACC Heart Failure ·Jordan B. King, Rashmee U. Shah, Adam P. Bress, Richard E. Nelson, Brandon K. Bellows	2016	107
11	A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States Antimicrobial Resistance and Infection Control ·Daniel J. Livorsi, Margaret L. Chorazy, Marin L. Schweizer, Erin Balkenende, Amy Blevins, Rajeshwari Nair, Matthew H. Samore, Richard E. Nelson, Karim Khader, Eli N. Perencevich	2018	90
12	Incidence and Outcomes Associated WithClostridium difficileInfections JAMA Network Open ·Alexandre R. Marra, Eli N. Perencevich, Richard E. Nelson, Matthew H. Samore, Karim Khader, Hsiu‐Yin Chiang, Margaret L. Chorazy, Loreen A. Herwaldt, Daniel J. Diekema, Michelle Kuxhausen, Amy Blevins, Melissa Ward, Jennifer S. McDanel, Rajeshwari Nair, Erin Balkenende, Marin L. Schweizer	2020	90
13	Incidence and Outcomes Associated With Infections Caused by Vancomycin-Resistant Enterococci in the United States: Systematic Literature Review and Meta-Analysis Infection Control and Hospital Epidemiology ·Hsiu‐Yin Chiang, Eli N. Perencevich, Rajeshwari Nair, Richard E. Nelson, Matthew H. Samore, Karim Khader, Margaret L. Chorazy, Loreen A. Herwaldt, Amy Blevins, Melissa Ward, Marin L. Schweizer	2016	88
14	Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations Current Medical Research and Opinion ·Diana Brixner, Kenneth C. Jackson, Xiaoming Sheng, Richard E. Nelson, A. Keskinaslan	2008	79
15	Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia JAMA Internal Medicine ·Barbara Jones, Jian Ying, Vanessa Stevens, Candace Haroldsen, Tao He, McKenna Nevers, Matthew A. Christensen, Richard E. Nelson, Gregory J. Stoddard, Brian C. Sauer, Peter M. Yarbrough, Makoto Jones, Matthew Bidwell Goetz, Tom Greene, Matthew H. Samore	2020	71
16	Mortality, Length of Stay, and Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Elderly Hospitalized Patients in the United States Clinical Infectious Diseases ·Richard E. Nelson, David Y. Hyun, Amanda Jezek, Matthew H. Samore	2021	63
17	Attributable Mortality of Healthcare-Associated Infections Due to Multidrug-Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus Aureus Infection Control and Hospital Epidemiology ·Richard E. Nelson, Rachel B. Slayton, Vanessa Stevens, Makoto Jones, Karim Khader, Michael Rubin, John A. Jernigan, Matthew H. Samore	2017	58
18	Cost-Effectiveness Analysis of Fecal Microbiota Transplantation for RecurrentClostridium difficileInfection Infection Control and Hospital Epidemiology ·Raghu Varier, Eman Biltaji, Kenneth J. Smith, Mark S. Roberts, M. Kyle Jensen, Joanne LaFleur, Richard E. Nelson	2015	53
19	Testing the Fetal Origins Hypothesis in a developing country: evidence from the 1918 Influenza Pandemic Health Economics ·Richard E. Nelson	2009	53
20	Economic Analysis of Rapid and Sensitive Polymerase Chain Reaction Testing in the Emergency Department for Influenza Infections in Children The Pediatric Infectious Disease Journal ·Richard E. Nelson, Chris Stockmann, Adam L. Hersh, Andrew T. Pavia, Kent Korgenksi, Judy A. Daly, Marc Roger Couturier, Krow Ampofo, Emily A. Thorell, Elizabeth H. Doby, Jeff A. Robison, Anne J. Blaschke	2015	50

About Richard E. Nelson

Richard E. Nelson is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Critical Care and Intensive Care Medicine, Molecular Medicine and General Health Professions, having authored 223 papers that have together received 4.5k indexed citations. Recurring topics across this work include Healthcare Policy and Management (23 papers), Clostridium difficile and Clostridium perfringens research (23 papers), Antimicrobial Resistance in Staphylococcus (18 papers), Health Systems, Economic Evaluations, Quality of Life (17 papers), Antibiotic Use and Resistance (16 papers), Homelessness and Social Issues (15 papers), Hip and Femur Fractures (11 papers) and Bone health and osteoporosis research (10 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (438 citations), Molecular Medicine (555 citations), Internal Medicine (358 citations), Critical Care and Intensive Care Medicine (294 citations) and Infectious Diseases (918 citations). Richard E. Nelson has collaborated with scholars based in United States, Australia and Switzerland. Frequent co-authors include Matthew H. Samore, Scott D. Grosse, Karim Khader, Vanessa Stevens, Lisa C. Richardson, Kwame A. Nyarko, Gary E. Raskob, Joanne LaFleur, Michael Rubin and John A. Jernigan. Their work appears in journals such as Infection Control and Hospital Epidemiology, Clinical Infectious Diseases, Open Forum Infectious Diseases, JAMA Network Open and Medical Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact